Fig. 5From: DARS2 overexpression is associated with PET/CT metabolic parameters and affects glycolytic activity in lung adenocarcinomaIn patients with low or high 18F-FDG levels of LAUD, expression of DARS2 was compared. A, B Representative PET/CT images for LUAD patients with different SUVmax values. C, D IHC staining for DARS2 in LUAD patients with high (n = 31) and low (n = 31) SUVmax values. ***p < 0.001Back to article page